Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex, and Parkinson's disease-related changes
- PMID: 36354307
- DOI: 10.1111/jnc.15723
Cerebrospinal fluid and blood profiles of transfer RNA fragments show age, sex, and Parkinson's disease-related changes
Abstract
Transfer RNA fragments (tRFs) have recently been shown to be an important family of small regulatory RNAs with diverse functions. Recent reports have revealed modified tRF blood levels in a number of nervous system conditions including epilepsy, ischemic stroke, and neurodegenerative diseases, but little is known about tRF levels in the cerebrospinal fluid (CSF). To address this issue, we studied age, sex, and Parkinson's disease (PD) effects on the distributions of tRFs in the CSF and blood data of healthy controls and PD patients from the NIH and the Parkinson's Progression Markers Initiative (PPMI) small RNA-seq datasets. We discovered that long tRFs are expressed in higher levels in the CSF than in the blood. Furthermore, the CSF showed a pronounced age-associated decline in the level of tRFs cleaved from the 3'-end and anti-codon loop of the parental tRNA (3'-tRFs, i-tRFs), and more pronounced profile differences than the blood profiles between the sexes. In comparison, we observed moderate age-related elevation of blood 3'-tRF levels. In addition, distinct sets of tRFs in the CSF and in the blood segregated PD patients from controls. Finally, we found enrichment of tRFs predicted to target cholinergic mRNAs (Cholino-tRFs) among mitochondrial-originated tRFs, raising the possibility that the neurodegeneration-related mitochondrial impairment in PD patients may lead to deregulation of their cholinergic tone. Our findings demonstrate that the CSF and blood tRF profiles are distinct and that the CSF tRF profiles are modified in a sex-, age-, and disease-related manner, suggesting that they reflect the inter-individual cerebral differences and calling for incorporating this important subset of small RNA regulators into future studies.
© 2022 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry.
References
REFERENCES
-
- Anderson, P., & Ivanov, P. (2014). tRNA fragments in human health and disease. FEBS Letters, 588, 4297-4304.
-
- Balatti, V., Rizzotto, L., Miller, C., Palamarchuk, A., Fadda, P., Pandolfo, R., Rassenti, L. Z., Hertlein, E., Ruppert, A. S., Lozanski, A., Lozanski, G., Kipps, T. J., Byrd, J. C., Croce, C. M., & Pekarsky, Y. (2015). TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 112, 2169-2174.
-
- Balédent, O., Gondry-Jouet, C., Meyer, M. E., Marco, G., De Gars, D., Le Henry-Feugeas, M. C., & Idy-Peretti, I. (2004). Relationship between cerebrospinal fluid and blood dynamics in healthy volunteers and patients with communicating hydrocephalus. Investigative Radiology, 39, 45-55.
-
- Bartel, D. P. (2018). Metazoan MicroRNAs. Cell, 173, 20-51.
-
- Bohn, J. P., Reinstadler, V., Pall, G., Stockhammer, G., Steurer, M., Oberacher, H., & Wolf, D. (2019). Cerebrospinal fluid drug concentrations and clinical outcome of patients with neoplastic meningitis treated with liposomal Cytarabine. European Journal of Drug Metabolism and Pharmacokinetics, 44, 845-851.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
